Verid Bio does not sell one way. The same platform — the same sensor, the same quality system, the same engineering team — is available as SKD components for local manufacturing, as a finished OEM device carrying your brand, or through exclusive distribution of the Verid Bio brand. The model changes your obligations, not your product.
Everything else follows from that one answer. If we finish the device, you are importing a medical device. If you finish the device, your market treats it as locally manufactured — and that changes duty, registration and tender eligibility at the same time.
This is why the three models are not a pricing ladder. They are three different legal and commercial positions, and the right one depends on what your organisation already has: a facility, a regulatory team, a sales channel, or a tender book.
Where two models could work, we will say so — and we will tell you which one we think will cost you less over three years, not which one is easier to sell today.
Not sure which applies? The selector below takes about 40 seconds.
Open the selector →You have — or can build — an assembly area and a quality system.
You have a brand and a channel, but no manufacturing footprint.
You have clinical relationships, a tender book or a pharmacy network.
Eleven dimensions that decide which model is right — including the two that are usually left out of the conversation: capital at risk, and who controls the product after launch.
| Dimension | SKD | OEM / private label | Distribution |
|---|---|---|---|
| What arrives | Core components, tested and calibrated | Finished, certified device | Finished device, Verid Bio brand |
| Who finishes the device | Your team, with SOPs and training | Verid Bio | Verid Bio |
| Local investment | Assembly area, cleanroom, trained staff, registration | Inventory and marketing | Inventory, marketing and clinical selling |
| Duty & local content | Locally manufactured treatment | Imported finished device | Imported finished device |
| Registration holder | Your organisation, with our technical file | Verid Bio, under a brand licence | Verid Bio |
| Tender eligibility | Local-content programmes open | Limited | Limited |
| Brand & lifecycle control | Packaging, manual, language, app | Packaging and channel | Channel only |
| Software & app | Your brand, our certified platform | Your brand build | Verid Bio app |
| Time to first sale | Longest — facility, training and your own filing | Shortest | Short, once stock is landed |
| Capital at risk | Highest — capability, not just inventory | Moderate — minimum order and marketing | Lowest — stock and market development |
| Best for | Pharmacy chains, distributors going brand-owner, government programme operators | Brand owners, telehealth platforms, retail groups | Medical device distributors, clinic networks, importers |
Where a market restricts local manufacturing or requires a local agent, the sequencing in the next section usually resolves it.
Most partners do not begin with SKD. They begin with distribution or OEM to prove the market, then move to local manufacturing once volume justifies the facility. The kit configuration, the brand and the registration path are designed to allow that progression without starting over.
Distribution or OEM. Stock, clinical evidence, reference accounts, tender history.
Private label with your packaging, manual and app language.
SKD assembly, your registration, local-content eligibility, then deeper transfer.
This is the same sequence our team runs on a first call. It is not a quote — it tells you which page to read next.
Yes, and several partners do — typically OEM for one brand in their portfolio and distribution for another. What we do not do is place two partners in the same country fighting over the same channel, so the territory structure is agreed before signature whichever model applies.
No. The sensor platform, the accuracy specification and the quality system are identical across all three. What changes is the scope of what we supply, the obligations attached to the device, and therefore the landed cost structure and the commercial terms.
Distribution and OEM are the most common starting points because they do not require local manufacturing capability. SKD is the fastest-growing model in markets with local-content programmes, because it is the only one that changes a partner's tender eligibility.
That points to SKD. You file in your own name and become the local manufacturer, using the technical file we supply. If you are not ready for assembly yet, OEM under a brand licence plus a local authorised representative is the usual interim route.
It is a commercial amendment, not a new product. The platform, the app and the kit configuration carry across, so the progression from distribution to OEM to SKD does not restart the technical work.
Send your country, your current channel and whether you have a facility. You will get a straight answer on which of the three models we would recommend — and what would have to be true for the next tier up.